While many of the largest healthcare companies have seen rising revenues and record profits at the start of 2019, stock prices aren’t reflecting their successes, Axios reported.

Amputations that are a result of diabetic complications are a life-changing action when the disease spirals out of control. As the prevalence of the disease continues to rise––30 million Americans are estimated to have diabetes––black and Latino patients are more likely to have an amputation compared to non-Hispanic whites, CNN reports.

With more policymakers proposing, supporting and seriously considering various Medicare-for-all health plans, the Congressional Budget Office took a look at a possible design of such a healthcare system and published a highly anticipated paper.

CMS has finalized a rule to ensure that states cannot divert portions of Medicaid provider payments to third parties beyond what is allowed in the statute.

Aetna’s legal department remains busy. Days after the company settled out of court with a patient who sued for coverage denial in California, it’s in the news in Florida for much the same reason—but with a bigger claimant.

A pilot that aims to study the use of blockchain-enabled data technology to track and verify specialty prescription drugs has been approved by the FDA.

CVS Health, fresh off a $69 billion takeover of health insurance giant Aetna, saw its revenues increase 34.8% to $61.6 billion during the first quarter of 2019, according to a May 1st earnings report. In addition, net income rose 43%, to $1.4 billion, from the previous year.

As bacterial germs continue to mutate and proliferate due to the overuse of antibiotics, an arm of the United Nations is laying out the disturbing numbers in hopes of stirring people to action all around the world.